Ubs Group Ag Bio Rad Laboratories, Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 29,227 shares of BIO stock, worth $9.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,227
Previous 52,910
44.76%
Holding current value
$9.67 Million
Previous $14.5 Million
32.33%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$513 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$431 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$359 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$236 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.15B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...